New publications in health economics and genomics 4th January 2022

A bumper crop of publications from the holiday period:

  • Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases | link
  • The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence | link
  • Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy | link
  • Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link
  • The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening | link
  • Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s